Halozyme Therapeutics, Inc.

Erste Asset Management GmbH HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

34,800

Value ($000)

2,399

Weight

0.0%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	2,399	0.0%	34,800	12/31/2025
2025 Q3	11/12/2025	2,550	0.0%	34,800	9/30/2025
2025 Q2	8/14/2025	1,817	0.0%	34,800	6/30/2025
2025 Q1	5/14/2025	3,052	0.0%	47,800	3/31/2025
2024 Q4	2/10/2025	2,301	0.0%	47,800	12/31/2024
2024 Q3	11/14/2024	2,723	0.0%	47,800	9/30/2024
2024 Q2	11/26/2024	2,468	0.0%	47,800	6/30/2024
2024 Q1	11/26/2024	1,947	0.0%	47,800	3/31/2024
2023 Q4	11/26/2024	1,776	0.0%	47,800	12/31/2023
2023 Q3	11/26/2024	1,871	0.0%	47,800	9/30/2023
2023 Q2	11/26/2024	1,657	0.0%	47,800	6/30/2023
2023 Q1	11/26/2024	1,783	0.0%	47,800	3/31/2023
2022 Q4	11/26/2024	2,724	0.1%	47,800	12/31/2022
2022 Q3	11/26/2024	1,889	0.0%	47,800	9/30/2022
2022 Q2	11/26/2024	2,164	0.0%	47,800	6/30/2022
2022 Q1	11/25/2024	1,923	0.0%	47,800	3/31/2022
2021 Q4	11/25/2024	2,164	0.0%	53,700	12/31/2021
2021 Q3	11/25/2024	2,129	0.0%	53,700	9/30/2021
2021 Q2	11/25/2024	2,457	0.0%	53,700	6/30/2021
2021 Q1	11/25/2024	2,207	0.1%	53,700	3/31/2021
2020 Q4	11/25/2024	2,266	0.1%	53,700	12/31/2020
2020 Q3	11/25/2024	2,065	0.1%	77,900	9/30/2020
2020 Q2	11/22/2024	2,011	0.1%	77,900	6/30/2020
2020 Q1	11/22/2024	1,416	0.1%	77,900	3/31/2020
2019 Q4	11/22/2024	1,401	0.1%	77,900	12/31/2019
2019 Q3	11/22/2024	1,184	0.1%	77,900	9/30/2019
2019 Q2	11/22/2024	1,313	0.1%	77,900	6/30/2019
2019 Q1	11/22/2024	1,246	0.1%	77,900	3/31/2019
2018 Q4	11/26/2024	1,119	0.1%	77,900	12/31/2018